Aquestive Therapeutics appoints general counsel
Lori Braender joined specialty pharmaceutical company Aquestive Therapeutics on September 10 as senior vice president and general counsel.
Braender joined Aquestive following a 35-year career at law firm Day Pitney, where she was most recently chair of the life sciences practice group. In that role, she specialized in advising clients in pharmaceutical, biotechnology, medical device companies, hospitals and healthcare institutions on regulatory requirements, contractual arrangements and other business considerations connected with life science and healthcare transactions.
Aquestive focuses on identifying, developing and commercializing products to address unmet medical needs, according to the company.
Aquestive CEO Keith Kendall says in a statement: ‘With her knowledge and familiarity of the company, and the depth of her professional experience, Lori will be an important part of the leadership of Aquestive.’